Johnson & Johnson (1JNJ) Financial Statements
Johnson & Johnson Financial Overview
Johnson & Johnson's market cap is currently $586.91B. The company's EPS TTM is $6.60; its P/E ratio is 41.42; and it has a dividend yield of 1.83%. Johnson & Johnson is estimated to report earnings on January 26, 2027, and the estimated EPS forecast is $2.60. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 94.19B | $ 88.82B | $ 85.16B | $ 79.99B | $ 78.74B |
| Gross Profit | $ 63.94B | $ 61.35B | $ 58.61B | $ 55.39B | $ 55.34B |
| Operating Income | $ 25.60B | $ 22.15B | $ 23.41B | $ 21.01B | $ 20.94B |
| EBITDA | $ 41.05B | $ 24.78B | $ 23.32B | $ 26.61B | $ 26.75B |
| Net Income | $ 26.80B | $ 14.07B | $ 35.15B | $ 17.94B | $ 20.88B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.10B | $ 24.52B | $ 22.93B | $ 22.28B | $ 31.61B |
| Total Assets | $ 199.21B | $ 180.10B | $ 167.56B | $ 187.38B | $ 182.02B |
| Total Debt | $ 47.93B | $ 36.63B | $ 29.33B | $ 39.64B | $ 33.75B |
| Net Debt | $ 28.22B | $ 12.53B | $ 7.47B | $ 26.75B | $ 19.26B |
| Total Liabilities | $ 117.67B | $ 108.61B | $ 98.78B | $ 110.57B | $ 108.00B |
| Stockholders' Equity | $ 81.54B | $ 71.49B | $ 68.77B | $ 76.80B | $ 74.02B |
| Cash Flow | |||||
| Free Cash Flow | $ 19.70B | $ 19.84B | $ 18.25B | $ 17.18B | $ 19.76B |
| Operating Cash Flow | $ 24.53B | $ 24.27B | $ 22.79B | $ 21.19B | $ 23.41B |
| Investing Cash Flow | $ -23.59B | $ -18.60B | $ 878.00M | $ -12.37B | $ -8.68B |
| Financing Cash Flow | $ -5.54B | $ -3.13B | $ -15.82B | $ -8.87B | $ -14.05B |
Currency in USD